Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CD226
Description:
A gene encoding an immune-cell surface receptor involved in cell adhesion and activation of innate and adaptive immune responses.
Related topics:
Immune Cell Function and Interaction (18%),
Cancer Immunotherapy and Biomarkers (18%),
T-cell and B-cell Immunology (10%)
Wikidata ID:
wiki/Q18035590
OpenAlex ID:
keywords/cd226
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
2014
·
Robert J. Johnston
, Laetitia Comps-Agrar
, et al.
·
Cancer Cell
·
1,256
PDF
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
2003
·
Cristina Bottino
, Roberta Castriconi
, et al.
·
The Journal of Experimental Medicine
·
934
PDF
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
2015
·
Joe-Marc Chauvin
, Ornella Pagliano
, et al.
·
Journal of Clinical Investigation
·
820
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
2011
·
Nicole Joller
, Jason P Hafler
, et al.
·
The Journal of Immunology
·
610
PDF
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
2014
·
Christopher J Chan
, Ludovic Martinet
, et al.
·
Nature Immunology
·
530
Balancing natural killer cell activation through paired receptors
2015
·
Ludovic Martinet
, Mark J. Smyth
·
Nature reviews. Immunology
·
504
The TIGIT/CD226 Axis Regulates Human T Cell Function
2012
·
Ester Lozano
, Margarita Dominguez-Villar
, et al.
·
The Journal of Immunology
·
499
TIGIT and CD 96: new checkpoint receptor targets for cancer immunotherapy
2017
·
William C. Dougall
, Sema Kurtulus
, et al.
·
Immunological Reviews
·
459
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
2022
·
Karl L. Banta
, Xiaozheng Xu
, et al.
·
Immunity
·
404
PDF
Vstm3 is a member of the CD28 family and an important modulator of T‐cell function
2011
·
Steven D. Levin
, David W. Taft
, et al.
·
European Journal of Immunology
·
361
PDF
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
2018
·
Haoyu Sun
, Qiang Huang
, et al.
·
Hepatology
·
320
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
2004
·
S. Tahara-Hanaoka
, Kazuko Shibuya
, et al.
·
International Immunology
·
303
DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions
2004
·
Nicolas Reymond
, Anne-Marie Imbert
, et al.
·
The Journal of Experimental Medicine
·
283
PDF
Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141
2005
·
Peter Tomasec
, Eddie C Y Wang
, et al.
·
Nature Immunology
·
276
High-Resolution Transcriptome of Human Macrophages
2012
·
Marc Beyer
, Michael R. Mallmann
, et al.
·
PLoS ONE
·
274
PDF
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
2015
·
Christopher A Fuhrman
, Wen-I Yeh
, et al.
·
The Journal of Immunology
·
271
Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells
2004
·
Roberta Castriconi
, Alessandra Dondero
, et al.
·
Cancer Research
·
263
PDF
CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation
2003
·
Kazuko Shibuya
, Jun Shirakawa
, et al.
·
The Journal of Experimental Medicine
·
257
PDF
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
2022
·
Eugene Y Chiang
, Ira Mellman
·
Journal for ImmunoTherapy of Cancer
·
250
PDF
CD226 Gly307Ser association with multiple autoimmune diseases
2008
·
J P Hafler
, L M Maier
, et al.
·
Genes and Immunity
·
239
Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
2016
·
Stephen J. Blake
, William C. Dougall
, et al.
·
Clinical Cancer Research
·
230
PDF
Identification of CD112R as a novel checkpoint for human T cells
2016
·
Yuwen Zhu
, Alessandro Paniccia
, et al.
·
The Journal of Experimental Medicine
·
221
PDF
CD 155, an onco‐immunologic molecule in human tumors
2017
·
Jian Gao
, Qianqian Zheng
, et al.
·
Cancer Science
·
207
PDF
CD226 opposes TIGIT to disrupt Tregs in melanoma
2018
·
Julien Fourcade
, Zhaojun Sun
, et al.
·
JCI Insight
·
205
PDF
TIGIT: a novel immunotherapy target moving from bench to bedside
2018
·
Benjamin L. Solomon
, Ignacio Garrido-Laguna
·
Cancer Immunology Immunotherapy
·
204
Show more works
View as search
Works count:
923
Citation count:
24,870
Year
Topic
Type